Skip to main content

Research

The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.

July 15, 2015 In another disappointing turn, Diamyd Medical announced in late June that it was suspending a phase 3 trial for its GAD65 vaccine Diamyd. The US-based...
An African-American who has spent his entire career in corporate America, Donald is now the president and chief executive officer of a non-profit organization that -...
Dr. Jay Skyler weighs in on type 1 clinical trial design.
Learn about anti-CD3 therapy designed to slow or stop the progression of type 1 diabetes.
Dr. George Eisenbarth discusses the prevention of type 1 diabetes.
On July 29, the JDRF formally launched its innovative new online Clinical Trials Connection service. This service was launched to help patients with type 1 diabetes and...
Juvenile Diabetes Research Foundation President and CEO Dr. Alan Lewis discusses the organization's priorities, one year in.
While the benefits of exercise are well known, a recent study presented at the annual Scientific Sessions of the American Heart Association in November provided some...
As health care spending becomes an increasing concern, the cost associated with chronic disease – particularly diabetes – is becoming an important issue to consider. A...
Beta cell regeneration, dedifferentiation, redifferentiation, isolation, and encapsulation: this article reviews some of the leading curative research, profiling...
In April 2006, Dr. Louis Monnier and colleagues published an article in JAMA that challenged the conventional wisdom about diabetes management and complications.
What will it take to get an artificial pancreas approved? It seems that the path ahead may now be a bit clearer…
In mid-April, the popular press was full of reports on an exciting new paper published in the Journal of the American Medical Society on a stem-cell treatment for type 1...
The Journal of the American Medical Association (JAMA) published a controversial meta-analysis suggesting that people who are overweight (a body mass index [BMI] of 25-...
Weight expert Dr. David Cummings discusses why bariatric surgery goes far beyond weight loss for type 2 diabetes.
The artificial pancreas is coming – will it be connected to an iPhone? What we learned at Children with Diabetes - Focus on Technology.
A study in the Journal of the American Medical Association ( JAMA ) found that patients with type 2 diabetes who had been taking the GLP-1 agonists Bydureon (exenatide...
Can more type 2 therapies be used for type 1 diabetes?
Part 1 of our interview with the Helmsley Charitable Trust’s David Panzirer and T1D Exchange's Dana Ball.
Kelly’s transformative experience wearing an artificial pancreas for five days.

Pages